Arkolith/Insider Trading/ZVRA/Form 4

Thompson Rahsaan

Chief Legal & ComplianceZEVRA THERAPEUTICS, INC. (ZVRA) · full profile →Form 4 · filed Feb 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$36K
Net Open-Market Flow
-$36K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2026Sell(S)4K$8.83$36K50K
Jan 30, 2026Option exercise(M)11K——54K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 30, 2026Option exercise(M)11K—$023K
Jan 29, 2026Grant(A)38K—$038K
Jan 29, 2026Grant(A)75K—$075K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001788524-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ZEVRA THERAPEUTICS, INC.

Build

Ask your agent about ZVRA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001788524-26-000002"
Ask your agent
Use Arkolith to summarize insider buying and selling at ZEVRA THERAPEUTICS, INC.
over the last 90 days and cite the filings.